The Relative Strength (RS) Rating for Molina Healthcare climbed into a new percentile Wednesday, with a rise from 79 to 85.
Risk Management In The Stock Market: How Much Money To Invest Now
This exclusive rating from Investor's Business Daily measures price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
History shows that the best stocks tend to have an 80 or better RS Rating as they begin their biggest price moves.
Molina Healthcare broke out earlier, but has fallen back below the prior 338.33 entry from a cup with handle. If a stock you're watching clears a buy point then declines 7% or more below the original entry price, it's considered a failed base. It's best to wait for the stock to form a new consolidation and breakout. Also keep in mind that the most recent consolidation is a later-stage base, which makes it riskier to establish a new position or add shares to an existing one.
The company showed 15% EPS growth in the latest quarterly report, while sales growth came in at 16%. The company is expected to report its latest earnings and sales numbers on or around Apr. 23.
The company earns the No. 1 rank among its peers in the Medical-Managed Care industry group. Cigna Group and Alignment Healthcare are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
